This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-08-4330v1 69/7/2990    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yuan, J.-M. Articles by Hecht, S. S. Search for Related Content PubMed PubMed Citation Articles by Yuan, J.-M. Articles by Hecht, S. S.

Urinary Levels of Tobacco-Specific Nitrosamine Metabolites in Relation to Lung Cancer Development in Two Prospective Cohorts of Cigarette Smokers

¹ Masonic Cancer Center and ² Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota; ³ Department of Community, Occupational, and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; and ⁴ Department of Epidemiology, Shanghai Cancer Institute, Shanghai, People's Republic of China

Requests for reprints: Jian-Min Yuan, Division of Epidemiology and Community Health, University of Minnesota, 1300 South 2nd Street, Suite 300, Minneapolis, MN 55455. Phone: 612-625-8058; Fax: 612-624-0315; E-mail: jyuan{at}umn.edu.

Key Words: tobacco • NNK • NNAL • cotinine • lung cancer

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (sum of which is denoted as total NNAL) are metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). NNK and NNAL can induce lung cancer in laboratory animals but human data are limited. The association between prediagnostic levels of urinary total NNAL and risk of lung cancer development was evaluated in two prospective cohorts of Chinese cigarette smokers. We conducted a nested case-control study involving 246 cases of incident lung cancer and 245 cohort controls who were individually matched to the index cases by age, gender, neighborhood of residence at cohort enrollment, and date of urine collection. Urinary levels of total NNAL were significantly associated with risk of lung cancer in a dose-dependent manner. Relative to the lowest tertile, risks associated with the second and third tertiles of total NNAL were 1.43 [95% confidence interval (95% CI), 0.86–2.37] and 2.11 (95% CI, 1.25–3.54), respectively (P for trend = 0.005) after adjustment for self-reported smoking history and urinary total cotinine. Smokers in the highest tertiles of urinary total NNAL and total cotinine exhibited a 8.5-fold (95% CI, 3.7–19.5) increased risk for lung cancer relative to smokers with comparable smoking history but possessing the lowest tertiles of urinary total NNAL and total cotinine. Findings of the present study directly link NNK exposure to lung cancer development in humans. [Cancer Res 2009;69(7):2990–5]